The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab

Hanlim Pharm

Status: Enrolling

Conditions: Diabetes Mellitus, Type 2

Study type: Observational

Funder types: Industry

Identifiers

NCT06188234

HL-TNL/M-401

Details and patient eligibility

About

This study is to observe the prescription patterns and clinical efficacy of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment in routine clinical practice.

Full description

This study is to observe the clinical efficacy by analyzing the prescription patterns in routine clinical practice and changes in HbA1c, FPG, PP2G, etc., of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment. Additionally, the study intends to assess patient satisfaction based on these observations.

Enrollment: 3,000 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Adults over 19 years of age
2. Individuals diagnosed with type 2 diabetes.
3. Individuals who, at the clinical discretion, are prescribed Tenero Tab or Tenero M SR Tab for the purpose of diabetes treatment for the first time.
4. Individuals who have voluntarily provided written consent to participate in this study.

Exclusion criteria

1. Pregnant or breastfeeding women.
2. Individuals who are contraindicated according to the approved indications of Tenero Tab/Tenero M SR Tab.
3. Other cases where the principal investigator and study personnel deem individuals ineligible for participation in this clinical trial.